These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8532719)

  • 1. Hepatocarcinogenesis in transgenic mice.
    Sandgren EP; Merlino G
    Prog Clin Biol Res; 1995; 391():213-22. PubMed ID: 8532719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
    Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
    Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
    Liu P; Zhao Z; Dominique B
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations.
    Nguyen HQ; Danilenko DM; Bucay N; DeRose ML; Van GY; Thomason A; Simonet WS
    Oncogene; 1996 May; 12(10):2109-19. PubMed ID: 8668336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
    Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
    EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice.
    Abdullah Abu Musa DM; Kobayashi K; Yasuda I; Iijima M; Christoffels VM; Tomomura M; Horiuchi M; Ohnishi T; Kajihara T; Daikuhara Y; Lamers WH; Saheki T
    Mol Genet Metab; 1999 Nov; 68(3):346-56. PubMed ID: 10562461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease.
    Fausto N
    Semin Liver Dis; 1999; 19(3):243-52. PubMed ID: 10518304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells.
    Braun KM; Degen JL; Sandgren EP
    Nat Med; 2000 Mar; 6(3):320-6. PubMed ID: 10700235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis.
    Ma W; Xia X; Stafford LJ; Yu C; Wang F; LeSage G; Liu M
    Oncogene; 2006 Jul; 25(30):4207-16. PubMed ID: 16501603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the hormone-response elements of the proximal ApoA-I promoter, ApoCIII enhancer, and C/EBP binding site of the proximal ApoA-I promoter to the hepatic and intestinal expression of the ApoA-I and ApoCIII genes in transgenic mice.
    Kan HY; Georgopoulos S; Zanni M; Shkodrani A; Tzatsos A; Xie HX; Zannis VI
    Biochemistry; 2004 May; 43(17):5084-93. PubMed ID: 15109267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.
    Ma W; Tessarollo L; Hong SB; Baba M; Southon E; Back TC; Spence S; Lobe CG; Sharma N; Maher GW; Pack S; Vortmeyer AO; Guo C; Zbar B; Schmidt LS
    Cancer Res; 2003 Sep; 63(17):5320-8. PubMed ID: 14500363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonal regulation of gene expression during liver regeneration of urokinase transgenic mice.
    Locaputo S; Carrick TL; Bezerra JA
    Hepatology; 1999 Apr; 29(4):1106-13. PubMed ID: 10094954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-1 over-expression in transgenic mice inhibits hepatic preneoplasia.
    Lu S; Archer MC
    Mol Carcinog; 2003 Mar; 36(3):142-6. PubMed ID: 12619036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver.
    Masumoto N; Tateno C; Tachibana A; Utoh R; Morikawa Y; Shimada T; Momisako H; Itamoto T; Asahara T; Yoshizato K
    J Endocrinol; 2007 Sep; 194(3):529-37. PubMed ID: 17761892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.